X-153864670-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001278116.2(L1CAM):c.3081G>A(p.Ala1027Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000501 in 1,210,385 control chromosomes in the GnomAD database, including 5 homozygotes. There are 153 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0025 ( 2 hom., 75 hem., cov: 24)
Exomes 𝑓: 0.00029 ( 3 hom. 78 hem. )
Consequence
L1CAM
NM_001278116.2 synonymous
NM_001278116.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.34
Genes affected
L1CAM (HGNC:6470): (L1 cell adhesion molecule) The protein encoded by this gene is an axonal glycoprotein belonging to the immunoglobulin supergene family. The ectodomain, consisting of several immunoglobulin-like domains and fibronectin-like repeats (type III), is linked via a single transmembrane sequence to a conserved cytoplasmic domain. This cell adhesion molecule plays an important role in nervous system development, including neuronal migration and differentiation. Mutations in the gene cause X-linked neurological syndromes known as CRASH (corpus callosum hypoplasia, retardation, aphasia, spastic paraplegia and hydrocephalus). Alternative splicing of this gene results in multiple transcript variants, some of which include an alternate exon that is considered to be specific to neurons. [provided by RefSeq, May 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant X-153864670-C-T is Benign according to our data. Variant chrX-153864670-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 92932.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.34 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00255 (286/112342) while in subpopulation AFR AF= 0.00907 (281/30992). AF 95% confidence interval is 0.0082. There are 2 homozygotes in gnomad4. There are 75 alleles in male gnomad4 subpopulation. Median coverage is 24. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
L1CAM | NM_001278116.2 | c.3081G>A | p.Ala1027Ala | synonymous_variant | 24/29 | ENST00000370060.7 | NP_001265045.1 | |
L1CAM | NM_000425.5 | c.3081G>A | p.Ala1027Ala | synonymous_variant | 23/28 | NP_000416.1 | ||
L1CAM | NM_024003.3 | c.3081G>A | p.Ala1027Ala | synonymous_variant | 23/27 | NP_076493.1 | ||
L1CAM | NM_001143963.2 | c.3066G>A | p.Ala1022Ala | synonymous_variant | 22/26 | NP_001137435.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
L1CAM | ENST00000370060.7 | c.3081G>A | p.Ala1027Ala | synonymous_variant | 24/29 | 5 | NM_001278116.2 | ENSP00000359077.1 | ||
L1CAM | ENST00000361699.8 | c.3081G>A | p.Ala1027Ala | synonymous_variant | 23/27 | 1 | ENSP00000355380.4 | |||
L1CAM | ENST00000361981.7 | c.3066G>A | p.Ala1022Ala | synonymous_variant | 22/26 | 1 | ENSP00000354712.3 | |||
L1CAM | ENST00000370055.5 | c.3066G>A | p.Ala1022Ala | synonymous_variant | 23/27 | 5 | ENSP00000359072.1 |
Frequencies
GnomAD3 genomes AF: 0.00255 AC: 286AN: 112290Hom.: 2 Cov.: 24 AF XY: 0.00218 AC XY: 75AN XY: 34458
GnomAD3 genomes
AF:
AC:
286
AN:
112290
Hom.:
Cov.:
24
AF XY:
AC XY:
75
AN XY:
34458
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000790 AC: 145AN: 183449Hom.: 0 AF XY: 0.000560 AC XY: 38AN XY: 67883
GnomAD3 exomes
AF:
AC:
145
AN:
183449
Hom.:
AF XY:
AC XY:
38
AN XY:
67883
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000292 AC: 321AN: 1098043Hom.: 3 Cov.: 33 AF XY: 0.000215 AC XY: 78AN XY: 363413
GnomAD4 exome
AF:
AC:
321
AN:
1098043
Hom.:
Cov.:
33
AF XY:
AC XY:
78
AN XY:
363413
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00255 AC: 286AN: 112342Hom.: 2 Cov.: 24 AF XY: 0.00217 AC XY: 75AN XY: 34520
GnomAD4 genome
AF:
AC:
286
AN:
112342
Hom.:
Cov.:
24
AF XY:
AC XY:
75
AN XY:
34520
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Sep 26, 2012 | - - |
Spastic paraplegia Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 27, 2016 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Sep 21, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at